Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles

@article{Mesulam1999NeuroplasticityFI,
  title={Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles},
  author={M.-Marsel Mesulam},
  journal={Neuron},
  year={1999},
  volume={24},
  pages={521-529}
}
  • M. Mesulam
  • Published 1 November 1999
  • Psychology, Medicine
  • Neuron
Supported in part by an Alzheimer's Disease Center grant AG13854 from the National Institute on Aging and grant NS20285 from the National Institute of Neurological Disorders and Stroke. 
The Cellular Phase of Alzheimer’s Disease
Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology
TLDR
It is reported that Alzheimer’s disease pathology specifically affects brain regions with certain molecular properties, and that the biological pathways underlying this vulnerability differ for amyloid accumulation versus neurodegeneration.
Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration
TLDR
Using multimodal biomarkers and longitudinal structural imaging in two large independent datasets, Fernández-Cabello et al. find robust evidence in favour of the former: cortical origin versus subcortical origin.
Cascading network failure across the Alzheimer’s disease spectrum
TLDR
An in-depth analysis of changes within subsystems within the default mode network are related to biomarker profiles across the Alzheimer’s disease spectrum and results support a cascading network failure model of Alzheimer's disease.
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia
To identify predictors of Alzheimer's disease (AD) versus frontotemporal lobar degeneration pathology in primary progressive aphasia (PPA), and determine whether the AD pathology is atypically
Alzheimer's disease: synaptic dysfunction and Aβ
TLDR
The evidence that non-fibrillar soluble forms of Aβ are mediators of synaptic compromise is reviewed and the possible mechanisms of A β synaptotoxicity and potential targets for therapeutic intervention are discussed.
BRAIN CHOLESTEROL PATHOLOGY IS THE CAUSE OF ALZHEIMER'S DISEASE
TLDR
The objective was to establish an experimental procedure and show direct results that unequivocally can be assigned as neurodegeneration and not as a result of prior research into “black-box” cases.
A network dysfunction perspective on neurodegenerative diseases
TLDR
Patients with Alzheimer's disease or other neurodegenerative disorders show remarkable fluctuations in neurological functions, even during the same day, which are likely to reflect variations in the activity of neural networks and chronic intoxication by abnormal proteins that the brain is temporarily able to overcome.
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
TLDR
The pathophysiology of AD is elucidates and the need to explore the mitochondrial pathways is emphasized to provide solutions to unanswered questions in the prevention and treatment of AD.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 236 REFERENCES
Apolipoprotein E and Alzheimer's disease.
TLDR
This work has shown that Isoform-specific interactions of apolipoprotein E with other molecules determine the outcome from other neurologic disorders and may provide more tractable model systems.
Alzheimer's disease: maladaptive synaptoplasticity hypothesis.
  • D. Neill
  • Psychology, Medicine
    Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration
  • 1995
TLDR
A maladaptive synaptoplastic response, in conjunction with an involution of cortico-cortical projection neurons, as the principal causative events in Alzheimer's disease are proposed.
HEAD INJURY AND THE RISK OF ALZHEIMER'S DISEASE: A CASE CONTROL STUDY
TLDR
This study examines the association between Alzheimer's disease and head injury in elderly patients referred to an EMI unit and finds no link between the diseases and each other.
Neuron loss in APP transgenic mice
TLDR
It is reported that these mice exhibit selective neuronal death in the brain regions that are most affected in AD, suggesting that amyloid plaque formation is directly involved in AD neuron loss.
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
Multiple neurotransmitter deficits found in recent autopsy studies of patients with Alzheimer's disease may militate against the success of "simple cholinergic replacement" as treatment. To study
Early and rapid de novo synthesis of Alzheimer βA4‐Amyloid precursor protein (APP) in activated microglia
Upon acute activation, microglia, the immuneffector cells of the brain parenchyma, express the amyloid precursor protein (APP) that is otherwise prominent in pathological structures related to
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
TLDR
Both linear regressions and multivariate analyses correlating three global neuropsychological tests with a number of structural and neurochemical measurements performed on a prospective series of patients with Alzheimer's disease and 9 neuropathologically normal subjects reveal very powerful correlations with all three psychological assays.
...
1
2
3
4
5
...